Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Virpax Pharmaceuticals, Inc. (VRPX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Gross profit | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research and development | 37.9% | 67.9% | 14.0% | 35.8% | 53.3% | 63.2% | 13.0% | 50.4% |
| General and administrative | 62.1% | 28.1% | 107.0% | 64.2% | 46.7% | 37.0% | 24.4% | 49.6% |
| EBIT | -95.0% | -86.8% | -162.5% | -98.5% | -96.6% | -96.9% | -26.9% | -96.4% |
| Pre-tax income | -91.3% | -83.6% | -136.4% | -97.6% | -96.3% | -97.2% | -30.6% | -95.4% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -91.3% | -83.6% | -136.4% | -97.6% | -96.3% | -97.2% | -30.6% | -95.4% |
|